Newsletter | October 6, 2026

10.06.26 -- Why The Lowest Price Can Become The Most Expensive Choice In Clinical Trials

FEATURED EDITORIAL

Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward

This third installment of our Root Causes video series examines how administrative complexity can consume resources that might otherwise improve clinical trial execution.

 

Token Costs Will Decide Clinical Supply AI

AI may make clinical supply forecasting faster, but cheaper tokens can drive higher costs. See how to measure AI at scale before a pilot becomes an expensive surprise.

 

The Hidden Cost Of The "Cheap" Comparator Drug: Why The Lowest Price Can Become The Most Expensive Choice In Clinical Trials

The cheapest comparator can become the costliest choice. See how shelf life, logistics, quality, wastage and supply continuity can turn apparent savings into trial risk.

 

INDUSTRY INSIGHTS

 

Designing Risk-Based Containment For Potent API Micronization

This session presents a risk-based framework for high-potency micronization, illustrated through a practical case study that spans development to commercial scale.

 

The Critical Role Of UK And EU Qualified Persons

Gain essential insights into QP roles, regulatory updates, and best practices for ensuring compliance, supply continuity, and safe handling of cold and frozen pharmaceutical products across the UK and EU.

MORE GREAT EDITORIAL

Designing Clinical Trials For Hard-To-Access Patients

Expanding clinical trials to underserved patients depends on resilient, flexible supply chains that overcome geography, infrastructure, and logistical challenges.

Solving Pharmacy And Clinical Supply Challenges In Decentralized Trials

Decentralized trials promise better patient access but create major supply risks. From cold chain failures to regulatory hurdles, here is what sponsors must solve now.

At The Point Of Review: How Clinical Shipments Are Evaluated In Practice

At review, clinical shipments become a single consolidated record. Delays arise when relationships between product identity, classification, and documentation are unclear.